Chemotherapy of acute leukemia in adults.
D015250:Aclarubicin; D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy* / Q000628:therapy; D009279:Naphthacenes / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007370:Interferon Type I; D009279:Naphthacenes; D003561:Cytarabine; C047643:N(4)-palmitoyl cytarabine; D015250:Aclarubicin; D004317:Doxorubicin; C015019:enocitabine; C027260:pirarubicin